Cystic Fibrosis
📧 Sign up to get email alerts when something new happens for Cystic Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-04-03Clinical Trial Update: A Phase 1 Study to Investigate the Food Effect of Lumacaftor in Combination With Ivacaftor [Phase 1]
A Phase 1 study evaluating the effect of food on the pharmacokinetics of lumacaftor when combined with ivacaftor in cystic fibrosis; the tri…
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: Concurrent Single Gene and 24 Chromosome Aneuploidy Preimplantation Genetic Diagnosis (PGD) [NA]
ClinicalTrials.gov shows completion of a study evaluating concurrent single-gene and 24-chromosome aneuploidy preimplantation genetic diagno…
-
CLINICAL_TRIALS trial_result · 2014-03-26Clinical Trial Update: An Open-Label, Phase 1 Study in Healthy Adult Subjects to Examine the Effects of Multiple-Dose Ciprofloxacin on Ivacaftor and VX-661 in Combination With Ivacaftor [Phase 1]
Open-label Phase 1 trial assessing the interaction of ciprofloxacin with ivacaftor and tezacaftor (VX-661) in healthy adults; completed.
-
CLINICAL_TRIALS trial_result · 2014-03-20Clinical Trial Update: A Phase 1 Study to Characterize the Effect of GS-5737 Enhancement of Mucociliary Clearance (MCC) in Healthy Subjects [Phase 1]
Phase 1 study evaluating the effect of GS-5737 on mucociliary clearance in healthy subjects; the trial sponsored by Gilead Sciences has been…
-
CLINICAL_TRIALS trial_result · 2014-03-17Clinical Trial Update: Long-term Study, Comparing Vest Therapy to Positive Expiratory Pressure (PEP) Therapy in the Treatment of Cystic Fibrosis [Phase 2]
A Phase 2 long-term trial comparing Vest Therapy to Positive Expiratory Pressure therapy for cystic fibrosis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-03-14Clinical Trial Update: Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis. [Phase 3]
A Phase 3 safety and efficacy trial evaluating two pancreatic enzyme formulations for exocrine pancreatic insufficiency in cystic fibrosis h…
-
CLINICAL_TRIALS trial_result · 2014-03-14Clinical Trial Update: Scandinavian Cystic Fibrosis Azithromycin Study [Phase 4]
Phase 4 trial evaluating azithromycin in cystic fibrosis has completed in Scandinavia.
-
CLINICAL_TRIALS trial_result · 2014-03-12Clinical Trial Update: Safety and Efficacy Study of ULTRASE® MT20 in Participants With Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (PI) [Phase 3]
Phase 3 safety and efficacy results for ULTRASE MT20 in people with cystic fibrosis and exocrine pancreatic insufficiency, with the study co…
-
CLINICAL_TRIALS trial_result · 2014-03-11Clinical Trial Update: Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis and Chronic Burkholderia Species Infection [Phase 3]
Phase 3 trial evaluating safety and efficacy of Aztreonam for inhalation solution (AZLI) in cystic fibrosis patients with chronic Burkholder…
-
FDA approval · 2014-03-07FDA Approved: PANCREAZE — Supplemental Application (VIVUS LLC)
FDA approved a supplemental application for PANCREAZE (pancrelipase) submitted by VIVUS LLC.
-
CLINICAL_TRIALS trial_result · 2014-03-07Clinical Trial Update: PR-018: An Open-Label, Safety Extension of Study PR-011 [Phase 4]
Open-label safety extension of study PR-011 (PR-018) in Cystic Fibrosis with Exocrine Pancreatic Insufficiency; Phase 4 completed with resul…
-
CLINICAL_TRIALS trial_result · 2014-03-07Clinical Trial Update: Miglustat in Cystic Fibrosis [Phase 2]
Phase 2 trial of miglustat in cystic fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-06Clinical Trial Update: Treatment of Low Bone Density in Cystic Fibrosis. [Phase 3]
Phase 3 clinical trial update on treatment for low bone density in cystic fibrosis; the study has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-06Clinical Trial Update: Sitagliptin in Cystic Fibrosis-Related Diabetes [Phase 2]
A Phase 2 trial evaluating sitagliptin for cystic fibrosis-related diabetes has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-03-05Clinical Trial Update: Using Rheological Methods to Characterize Cystic Fibrosis (CF) Sputum and the Effects of Mucoactive Agents
The completed study used rheological methods to characterize cystic fibrosis sputum and evaluated the effects of mucoactive agents on sputum…
-
CLINICAL_TRIALS trial_result · 2014-03-04Clinical Trial Update: Inhaled Vancomycin Tolerability, Safety and Pharmacokinetics [Phase 1]
This Phase 1 trial evaluated tolerability, safety, and pharmacokinetics of inhaled vancomycin in healthy volunteers and cystic fibrosis pati…
-
FDA approval · 2014-02-21FDA Approved: KALYDECO — Supplemental Application (Vertex Pharmaceuticals Incorporated)
FDA approved a supplemental application for KALYDECO (ivacaftor) submitted by Vertex Pharmaceuticals Incorporated.
-
CLINICAL_TRIALS trial_result · 2014-02-21Clinical Trial Update: Improving Vitamin D Status In Cystic Fibrosis [NA]
A clinical trial investigated improving vitamin D status in people with cystic fibrosis; the study is completed and results were posted in 2…
-
CLINICAL_TRIALS trial_result · 2014-02-14Clinical Trial Update: Cystic Fibrosis Core Strengthening and Respiratory Exercise Program [Phase 2]
Phase 2 trial evaluating a cystic fibrosis core strengthening and respiratory exercise program has completed; no results are provided in the…
-
CLINICAL_TRIALS trial_result · 2014-02-14Clinical Trial Update: Treatment of Anxiety/Depression and Pain Through Relaxation Yoga for Patient With Cystic Fibrosis (CF) [Phase 2]
A Phase 2 clinical trial evaluating relaxation yoga to reduce anxiety, depression, and pain in cystic fibrosis patients has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-07Clinical Trial Update: Cough Efficiency in Cystic Fibrosis
A clinical trial evaluating cough efficiency in cystic fibrosis has completed.
-
CLINICAL_TRIALS withdrawal · 2014-01-30Clinical Trial Update: Statins To Treat Adult Cystic Fibrosis [Phase 1, Phase 2]
A Phase 1/2 trial investigating statin therapy for adults with cystic fibrosis and systemic inflammation has been withdrawn.
-
CLINICAL_TRIALS research · 2014-01-29Clinical Trial Update: Impact of Immunonutrition on the Patients With Cystic Fibrosis [Phase 4]
Phase 4 clinical trial update evaluating immunonutrition in patients with cystic fibrosis and malnutrition. The current status is unknown.
-
FDA approval · 2014-01-23FDA Approved: PERTZYE — Supplemental Application (Digestive Care, Inc.)
FDA approves a supplemental application for PERTZYE (pancrelipase) from Digestive Care, Inc., expanding its labeling/indication.
-
FDA approval · 2014-01-07FDA Approved: TOBI PODHALER — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for TOBI PODHALER (tobramycin) by Viatris Specialty LLC.